Real-time enrollment status for this diabetic peripheral neuropathy clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:38 AM UTC
| NCT Number | NCT06628908 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Peripheral Neuropathy |
| Phase | Clinical Trial |
| Target Enrollment | 1,100 participants |
| Active Locations | 76 sites in the US |
| Sponsor | Vertex Pharmaceuticals Incorporated |
| Last Updated on CT.gov | February 3, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT06628908 is currently recruiting participants. This clinical trial study for diabetic peripheral neuropathy is actively seeking new participants at 76 locations across the United States. The study is sponsored by Vertex Pharmaceuticals Incorporated. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06628908 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 76 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06628908 was last updated 3 weeks ago (February 3, 2026). HelloStudys verifies this status automatically.